Glenmark Pharmaceuticals Inc., USA recalls Nebivolol Tablets
- Recalling company
- Glenmark Pharmaceuticals Inc., USA
- Product
- Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.
- Reason
- Cross Contamination with Other Products
- Classification
- Class III – not likely to cause adverse health consequences
- Recall date
- Nov 18, 2025
- Reported
- Dec 17, 2025
- Distribution
- U.S. Nationwide
- Status
- Ongoing
- Quantity
- 672 90-count bottles
- Lot / codes
- Lot# 17240988; Exp. 05/31/2026
- Company location
- Mahwah, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0222-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0222-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.